Medtronic (MDT) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Medtronic (MDT)

MDT 92.21

+2.4%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dennis who wrote (506)	8/28/2000 10:39:20 PM
From: Jack Hartmann	Read Replies (1) of 687

Nice MDT article in the S&P Outlook today. Some Highlights. - Company is well positioned in the growing medical device field. - In the near future, management expects to achieve number one position in all its markets while pursuing opportunities in emerging areas such as congestive heart failure, next generation coronary stents, miniaturized pacemakers and abdominal aortic ancurysm grafts. - Expect 15% growth n the cardiac rhythm division - Expect vascular division to show revenue growth of 20% - Neurology division capable of 25% growth in FY 2001. - FY2001 revs expected to advance 18%, earnings to grow 20% - Five star rating as a core investment for superior long term gains. Jack

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next